A carregar...
New steps in infliximab therapeutic drug monitoring in patients with inflammatory bowel diseases
AIMS: Therapeutic drug monitoring (TDM) of infliximab (IFX) appears to be beneficial for patients with inflammatory bowel disease (IBD). However, the recommended target concentrations depend partly on the method used to quantify IFX. Since we recently developed a liquid chromatography–tandem mass sp...
Na minha lista:
| Publicado no: | Br J Clin Pharmacol |
|---|---|
| Main Authors: | , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
John Wiley and Sons Inc.
2019
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6422646/ https://ncbi.nlm.nih.gov/pubmed/30575085 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/bcp.13845 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|